ClearSeq Cancer

ClearSeq 癌症分析


ClearSeq Cancer is a comprehensive next generation sequencing target enrichment panel designed specifically for genetic anomalies in known cancer hotspots. This NGS application targets a set of 47 genes found in previous research to be associated with a broad range of cancer types as well as with published drug targets. The COSMIC database was the primary reference in the design process.Compatible with HaloPlexHS and HaloPlex Target Enrichment System

ClearSeq Cancer

ClearSeq Cancer is uniquely suited for high performance with cancer research samples, which are commonly preserved as formalin fixed and paraffin embedded (FFPE). This FFPE process often results in highly fragmented DNA, resulting in insufficient sequencing target coverage. FFPE also commonly produces small changes in single bases, cytosine to thymine, in DNA sequences. Unlike competitive technologies, HaloPlex covers each base with several amplicons, and smaller fragments function as a backup for longer fragments that may fail. This allows for high sequencing target coverage even in highly degraded FFPE samples.

產品列表

貨號 產品 數量
G9933A ClearSeq Cancer, HS, ILM 16 rxns
G9933B ClearSeq Cancer, HS, ILM 96 rxns
G9903A ClearSeq Cancer, ILM 16 rxns
G9903B ClearSeq Cancer, ILM 96 rxns
G9934A ClearSeq Cancer, HS, ION 16 rxns
G9934B ClearSeq Cancer, HS, ION 96 rxns
G9904A ClearSeq Cancer, ION 16 rxns
G9904B ClearSeq Cancer, ION 96 rxns

ClearSeq Cancer

  • Expert-optimized content - Contains target regions identified by researchers from leading cancer research institutions to be frequently mutated in cancer
  • Fast track to answers - Proven, high-performing capture oligos are coupled with highly efficient SureSelect and HaloPlex workflows, providing faster time to results and compatibility with samples of limited availability
  • Comprehensive Workflow Solution - Get from raw data to mutation report in 3 simple steps using SureCall analysis software
回到頂端